Browse by Academic Unit (A-Z)
|Up a level|
Abraham, S, Scarcia, M, Bagshaw, R et al. (15 more authors) (2015) A Rac/Cdc42 exchange factor complex promotes formation of lateral filopodia and blood vessel lumen morphogenesis. Nature Communications, 6. 7286. ISSN 2041-1723
Acquaviva, J, He, S, Zhang, C et al. (11 more authors) (2014) FGFR3 translocations in bladder cancer: differential sensitivity to HSP90 inhibition based on drug metabolism. Molecular Cancer Research, 12 (7). 1042 - 1054. ISSN 1541-7786
Ambrose, SR, Gordon, NS, Goldsmith, JC et al. (6 more authors) (2015) Use of Aleuria alantia Lectin Affinity Chromatography to Enrich Candidate Biomarkers from the Urine of Patients with Bladder Cancer. Proteomes, 3 (3). 266 - 282. ISSN 2227-7382
Baldia, PH, Maurer, A, Heide, T et al. (7 more authors) (2016) Fibroblast growth factor receptor (FGFR) alterations in squamous differentiated bladder cancer: a putative therapeutic target for a small subgroup. Oncotarget.
Blick, C, Ramachandran, A, Wigfield, S et al. (8 more authors) (2013) Hypoxia regulates FGFR3 expression via HIF-1α and miR-100 and contributes to cell survival in non-muscle invasive bladder cancer. British Journal of Cancer, 109 (1). pp. 50-59. ISSN 0007-0920
Brennan-Crispi, DM, Hossain, C, Sahu, J et al. (3 more authors) (2015) Crosstalk between Desmoglein 2 and Patched 1 accelerates chemical-induced skin tumorigenesis. Oncotarget, 6 (11). pp. 8593-8605.
Brownhill, S, Cohen, D and Burchill, S (2014) Proliferation Index: A Continuous Model to Predict Prognosis in Patients with Tumours of the Ewing's Sarcoma Family. PLOS ONE, 9 (8). e104106. ISSN 1932-6203
Brownhill, SC, Taylor, C and Burchill, SA (2007) Chromosome 9p21 gene copy number and prognostic significance of p16 in ESFT. British Journal of Cancer, 96 (12). pp. 1914-1923. ISSN 0007-0920
Bryan, RT, Regan, HL, Pirrie, SJ et al. (6 more authors) (2015) Protein shedding in urothelial bladder cancer: Prognostic implications of soluble urinary EGFR and EpCAM. British Journal of Cancer, 112 (6). 1052 - 1058. ISSN 0007-0920
Bunney, TD, Wan, S, Thiyagarajan, N et al. (8 more authors) (2015) The Effect of Mutations on Drug Sensitivity and Kinase Activity of Fibroblast Growth Factor Receptors: A Combined Experimental and Theoretical Study. EBiomedicine, 2 (3). 194 - 204.
Burchill, SA, Bradbury, MF, Pittman, K et al. (3 more authors) (1995) Detection of epithelial cancer cells in peripheral blood by reverse transcriptase-polymerase chain reaction. British Journal of Cancer, 71 (2). pp. 278-281. ISSN 0007-0920
Burchill, SA and Brownhill, SC (2016) PCR-based amplification of circulating RNAs as prognostic and predictive biomarkers – Focus on neuroblastoma. Practical Laboratory Medicine. ISSN 2352-5517
Burchill, SA, Lewis, IJ and Selby, P (1999) Improved methods using the reverse transcriptase polymerase chain reaction to detect tumour cells. British Journal of Cancer, 79 (5-6). pp. 971-977. ISSN 0007-0920
Burchill, SA, Perebolte, L, Johnston, C et al. (2 more authors) (2002) Comparison of the RNA-amplification based methods RT–PCR and NASBA for the detection of circulating tumour cells. British Journal of Cancer, 86 (1). pp. 102-109. ISSN 0007-0920
Burghel, GJ, Hurst, CD, Watson, CM et al. (4 more authors) (2015) Towards a Next-Generation Sequencing Diagnostic Service for Tumour Genotyping: A Comparison of Panels and Platforms. BioMed Research International, 2015. 478017. ISSN 2314-6133
De Faveri, LE, Hurst, CD orcid.org/0000-0001-7719-1325, Platt, FM et al. (5 more authors) (2013) Putative tumour suppressor gene necdin is hypermethylated and mutated in human cancer. British Journal of Cancer, 108 (6). pp. 1368-1377. ISSN 0007-0920
De Faveri, LE, Hurst, CD, Roulson, J et al. (4 more authors) (2015) Polycomb repressor complex 1 member, BMI1 contributes to urothelial tumorigenesis through p16-independent mechanisms. Translational Oncology, 8 (5). pp. 387-399. ISSN 1944-7124
Di Martino, E, Kelly, G, Roulson, JA et al. (1 more author) (2015) Alteration of cell-cell and cell-matrix adhesion in urothelial cells: An oncogenic mechanism for mutant FGFR3. Molecular Cancer Research, 13 (1). 138 - 148. ISSN 1541-7786
Di Martino, E, Taylor, CF, Roulson, J-A et al. (1 more author) (2013) An integrated genomic, transcriptional and protein investigation of FGFRL1 as a putative 4p16.3 deletion target in bladder cancer. Genes Chromosomes and Cancer, 52 (9). pp. 860-871. ISSN 1045-2257
Di Martino, E, Tomlinson, DC orcid.org/0000-0003-4134-7484, Williams, SV et al. (1 more author) (2016) A place for precision medicine in bladder cancer: targeting the FGFRs. Future Oncology, 12 (19). pp. 2243-2263. ISSN 1479-6694
Giedl, J, Rogler, A, Wild, A et al. (9 more authors) (2016) TERT Core Promotor Mutations In Early-Onset Bladder Cancer. Journal of Cancer, 7 (8). pp. 915-920. ISSN 1837-9664
Herrera-Abreu, MT, Pearson, A, Campbell, J et al. (4 more authors) (2013) Parallel RNA interference screens identify EGFR activation as an escape mechanism in FGFR3-mutant cancer. Cancer Discovery, 3 (9). 1058 - 1071. ISSN 2159-8274
Hurst, CD and Knowles, MA (2014) Molecular subtyping of invasive bladder cancer: time to divide and rule? Cancer Cell, 25 (2). 135 - 136. ISSN 1535-6108
Johnson, PWM, Burchill, SA and Selby, PJ (1995) The molecular detection of circulating tumour cells. British Journal of Cancer, 72 (2). pp. 268-276. ISSN 0007-0920
Kim, B, Stephen, SL, Hanby, AM et al. (9 more authors) (2015) Chemotherapy induces Notch1-dependent MRP1 up-regulation, inhibition of which sensitizes breast cancer cells to chemotherapy. BMC Cancer, 15. 634. ISSN 1471-2407
Knowles, MA and Hurst, CD (2014) Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity. Nature Reviews Cancer, 15 (1). 25 - 41. ISSN 1474-175X
Kovar, H, Alonso, J, Aman, P et al. (34 more authors) (2012) The first European interdisciplinary Ewing sarcoma research summit. Frontiers in Oncology, 2. 54.
Lerner, SP, Bajorin, DF, Dinney, CP et al. (32 more authors) (2016) Summary and Recommendations from the National Cancer Institute’s Clinical Trials Planning Meeting on Novel Therapeutics for Non-Muscle Invasive Bladder Cancer. Bladder Cancer, 2 (2). pp. 165-202. ISSN 2352-3727
Papadopoulos, V, Tsapakidis, K, Del Galdo, NAR et al. (6 more authors) (2016) The Prognostic Significance of the Hedgehog Signaling Pathway in Colorectal Cancer. Clinical Colorectal Cancer, 15 (2). pp. 116-127. ISSN 1533-0028
Pashankar, F, Hale, JP, Dang, H et al. (15 more authors) (2016) Is adjuvant chemotherapy indicated in ovarian immature teratomas? A combined data analysis from the Malignant Germ Cell Tumor International Collaborative. Cancer, 122 (2). pp. 230-237. ISSN 0008-543X
Patani, H, Bunney, TD, Thiyagarajan, N et al. (14 more authors) (2016) Landscape of activating cancer mutations in FGFR kinases and their differential responses to inhibitors in clinical use. Oncotarget, 7 (17). pp. 24252-24268. ISSN 1949-2553
Pouessel, D, Neuzillet, Y, Mertens, LS et al. (35 more authors) (2016) Tumor Heterogeneity of Fibroblast Growth Factor Receptor 3 (FGFR3) Mutations in Invasive Bladder Cancer: Implications for Peri-Operative anti-FGFR3 Treatment. Annals of Oncology, 27 (7). pp. 1311-1316. ISSN 0923-7534
Riley, RD, Abrams, KR, Sutton, AJ et al. (4 more authors) (2003) Reporting of prognostic markers: current problems and development of guidelines for evidence-based practice in the future. British Journal of Cancer, 88 (8). pp. 1191-1198. ISSN 0007-0920
Rippaus, N, Taggart, D, Williams, J et al. (4 more authors) (2016) Metastatic site-specific polarization of macrophages in intracranial breast cancer metastases. Oncotarget, 7 (27). pp. 41473-41487.
Ross, RL, McPherson, HR, Kettlewell, L et al. (4 more authors) (2016) PIK3CA dependence and sensitivity to therapeutic targeting in urothelial carcinoma. BMC Cancer, 16. 553. ISSN 1471-2407
Roundhill, EA and Burchill, SA (2012) Detection and characterisation of multi-drug resistance protein 1 (MRP-1) in human mitochondria. British Journal of Cancer, 106 (6). pp. 1224-1233. ISSN 0007-0920
Sethi, N, Prowse, S and Ghosh, S (2012) Hypocalcaemia following total thyroidectomy. Annals of Otology, Rhinology and Laryngology, 121 (12). 827 - 828 (1). ISSN 0003-4894
Stadler, LK, Tomlinson, DC, Lee, T et al. (2 more authors) (2014) The use of a neutral peptide aptamer scaffold to anchor BH3 peptides constitutes a viable approach to studying their function. Cell Death and Disease, 5. e1037. e1037 - e1037. ISSN 2041-4889
Sturla, L-M, Merrick, AE and Burchill, SA (2003) FGFR3IIIS: a novel soluble FGFR3 spliced variant that modulates growth is frequently expressed in tumour cells. British Journal of Cancer, 89 (7). pp. 1276-1284. ISSN 0007-0920
Trerotola, M, Ganguly, KK, Fazli, L et al. (12 more authors) (2015) Trop-2 is up-regulated in invasive prostate cancer and displaces FAK from focal contacts. Oncotarget, 6 (16). pp. 14318-14328.
Turo, R, Harnden, P, Thygesen, H et al. (5 more authors) (2015) FGFR3 expression in primary invasive bladder cancers and matched lymph node metastases. Journal of Urology, 193 (1). 325 - 330. ISSN 0022-5347
Weber, MR, Zuka, M, Lorger, M et al. (10 more authors) (2016) Activated tumor cell integrin αVβ3 cooperates with platelets to promote extravasation and metastasis from the blood stream. Thrombosis Research, 140 (1). S27-S36. ISSN 0049-3848
Wilson, EB, Meade, JL, Davison, AC et al. (2 more authors) (2014) Transforming growth factor-beta globally and specifically inhibits natural killer cells. In: Immunology. British Society for Immunology Annual Congress 2014, 01-04 Dec 2014, Brighton, UK. Wiley , 60 - 60.
Zhang, YF, Jeffrey, S, Burchill, SA et al. (3 more authors) (1998) Truncated human endothelin receptor A produced by alternative splicing and its expression in melanoma. British Journal of Cancer, 78 (9). pp. 1141-1146. ISSN 0007-0920